Success Metrics

Clinical Success Rate
100.0%

Based on 5 completed trials

Completion Rate
100%(5/5)
Active Trials
0(0%)
Results Posted
60%(3 trials)

Phase Distribution

Ph phase_1
2
40%
Ph phase_2
1
20%
Ph phase_3
2
40%

Phase Distribution

2

Early Stage

1

Mid Stage

2

Late Stage

Phase Distribution5 total trials
Phase 1Safety & dosage
2(40.0%)
Phase 2Efficacy & side effects
1(20.0%)
Phase 3Large-scale testing
2(40.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

5 of 5 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

5

all time

Status Distribution
Completed(5)

Detailed Status

Completed5

Development Timeline

Analytics

Development Status

Total Trials
5
Active
0
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 12 (40.0%)
Phase 21 (20.0%)
Phase 32 (40.0%)

Trials by Status

completed5100%

Recent Activity

0 active trials
Showing 5 of 5
completedphase_1

Dermal Safety Study to Evaluate Potential Irritation of Abametapir Lotion

NCT02061813
completedphase_2

Ovicidal Efficacy and Safety of Abametapir Lotion 0.74% Administered for the Treatment of Head Lice Infestation

NCT02097485
completedphase_3

A Study of the Efficacy and Safety of Abametapir Lotion Administered for the Treatment of Head Lice Infestation

NCT02060903
completedphase_3

Study of the Efficacy and Safety of Abametapir Lotion Administered for the Treatment of Head Lice Infestation

NCT02062060
completedphase_1

Dermal Safety Study to Evaluate the Sensitizing Potential of Abametapir Lotion

NCT02062073

Clinical Trials (5)

Showing 5 of 5 trials
NCT02061813Phase 1

Dermal Safety Study to Evaluate Potential Irritation of Abametapir Lotion

Completed
NCT02097485Phase 2

Ovicidal Efficacy and Safety of Abametapir Lotion 0.74% Administered for the Treatment of Head Lice Infestation

Completed
NCT02060903Phase 3

A Study of the Efficacy and Safety of Abametapir Lotion Administered for the Treatment of Head Lice Infestation

Completed
NCT02062060Phase 3

Study of the Efficacy and Safety of Abametapir Lotion Administered for the Treatment of Head Lice Infestation

Completed
NCT02062073Phase 1

Dermal Safety Study to Evaluate the Sensitizing Potential of Abametapir Lotion

Completed

All 5 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
5